Developing, manufacturing and commercializing bioresorbable devices to transform patient recovery

Two commercialized portfolios: ENT – NASOPORE^© and Peripheral Nerve Repair.

State-of-the-art manufacturing facilities for our ENT and PNR portfolios – over 5 million devices sold.

Broad technology platform, based on proprietary polymers and adhesives.

Strong research and development pipeline in Neurosurgery and General Surgery.

Multiple strategic partnerships with leading universities and centres of excellence.

Strong organizational structure, led by experienced and complementary executive team.